ACAD FY 2019 Earnings — ACADIA Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

ACADACADIA Pharmaceuticals Inc.

$4B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$339M+51.5% YoY

Gross Profit

$319M94.2% margin

Operating Income

-$247M-72.7% margin

Net Income

-$235M-69.4% margin

EPS (Diluted)

$-1.60

Cash Flow

Operating Cash Flow

-$151M

Free Cash Flow

-$152M

Stock-Based Comp.

$82M

Balance Sheet

Total Assets

$783M

Total Liabilities

$84M

Stockholders' Equity

$699M

Cash & Equivalents

$190M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$339M	$224M	+51.5%
Gross Profit	$319M	$205M	+55.5%
Operating Income	-$247M	-$247M	+0.4%
Net Income	-$235M	-$245M	+4.1%